PA28 β Antibodies

Santa Cruz Biotechnology offers a broad range of PA28 β monoclonal antibodies for advanced research in protein regulation and immune response. PA28 β monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PA28 β, also known as proteasome activator complex, enhances the proteolytic activity of the 26S proteasome, regulating protein degradation and turnover. PA28 β plays an essential role in processing antigenic peptides, which are vital for effective immune responses. Understanding PA28 β function provides insights into immune regulation mechanisms and potential therapeutic targets in various diseases. Researchers worldwide utilize PA28 β monoclonal antibodies to investigate cellular processes and disease mechanisms. PA28 β monoclonal antibodies enable detailed examination of protein-protein interactions and subcellular localization patterns. Santa Cruz Biotechnology PA28 β monoclonal antibodies support researchers in advancing scientific knowledge and developing innovative therapeutic strategies.